Investments
58 Investments in 53 Companies
Exits
4 IPOs & 13 Acquisitions
Headquarters:
Milan
Description:
Crédit Agricole Private Equity supports companies at all stages of their growth and expansion, from startup right through to sale.
Website:
http://www.ca-privateequity.com

Investor Details

Update
Founded:
Unknown
Contact:
Type:
Early Stage Venture, Later Stage Venture, Private Equity, and Debt Financing Investments
Sectors:
Software, Biotechnology, Health Care

Crédit Agricole Private Equity is the Crédit Agricole group's private equity arm. Its team of fifty professionals supports companies at all stages of their growth and expansion, from start-up right through to sale, in a long-term relationship of mutual trust and proximity.

As an active shareholder in over 250 companies, they aim at becoming a leading multi-specialist player in the private equity market. Their underlying goal is to provide investors with top tier quality management and investment returns while respecting the fundamental rules governing their business.

  • ividence
    Ividence is a stand-alone acquisition email ad exchange platform that uses behavioral targeting technology to match offers to audiences.
    Jun 4, 2012 - Invested in $4M Series B with 1 other
  • viavoo
    Viavoo is a France-based provider of sentiment and text analytics software for customer feedback.
    Dec 5, 2011 - Invested in €1.5M Series A
  • arGEN-X
    arGEN-X has invented and developed a platform for antibody lead choice in the discovery of human antibody therapeutics.
    Dec 1, 2011 - Invested in €32.5M Series B with 6 others
  • L'Usine à Design
    L’Usine à Design is a web platform that allows customized furniture orders.
    Sep 27, 2011 - Invested in $4M Series B
  • SpineGuard
    SpineGuard develops PediGuard® for pedicle screw placement and other applications in PediGuard technology platforms.
    Sep 27, 2011 - Invested in $6.2M Series B with 3 others
  • TrustYou
    TrustYou provides online reputation management tools to hotels, restaurants and destinations across the world.
    Sep 20, 2011 - Invested in $5M Series A
  • Amakem
    Amakem is a kinase platform company developing therapeutics for the treatment of serious eye conditions.
    Sep 6, 2011 - Invested in €18M Series A with 3 others
  • Aldebaran Robotics
    Aldebaran Robotics provides humanoid robots with mechanical, electronic, and cognitive features for entertainment purposes.
    Jun 8, 2011 - Invested in $13M Series C with 3 others

Offices/Locations (2)

Update
  • Office

    3 Azrieli Towers

    Tel Aviv,

    ISR

  • Office

    Piazza del Duomo, 17

    Milan, 20121

    ITA